Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2017 Cash Dividend Rate, and Reaffirms Fiscal 2017 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2017 Cash Dividend Rate, and Reaffirms Fiscal 2017 Guidance

Craig-Hallum Downgrades Meridian Biosciences (VIVO) to Hold

November 14, 2016 12:53 PM EST

Craig-Hallum downgraded Meridian Biosciences (NASDAQ: VIVO) from Buy to Hold.

For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.

Shares of Meridian Biosciences closed at $17.40 yesterday.

... More

Meridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.7% Yield

November 10, 2016 7:48 AM EST

Meridian Bioscience (NASDAQ: VIVO) declared a quarterly dividend of $0.20 per share, or $0.8 annualized.

The dividend will be payable on December 1, 2016, to stockholders of record on November 21, 2016, with an ex-dividend date of November 17, 2016.

The annual yield on the dividend is 4.7 percent.

For... More

Meridian Bioscience (VIVO) Reports In-Line Q4 EPS

November 10, 2016 7:48 AM EST

Meridian Bioscience (NASDAQ: VIVO) reported Q4 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $47 million versus the consensus estimate of $47.7 million.Meridian Bioscience reaffirmed FY2017 guidance.

For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.

... More